Mikkael A. Sekeres
AUTHOR

Mikkael A. Sekeres

Tap the gear icon above to manage new release emails.
Mikkael Sekeres is Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine. He earned a medical degree and a master’s degree in clinical epidemiology from the University of Pennsylvania School of Medicine. Dr Sekeres completed his postgraduate training at Harvard University, finishing an internal medicine residency at Massachusetts General Hospital and a fellowship in hematology-oncology at the Dana-Farber Cancer Institute in Boston. He is chair of the medical advisory board of the Aplastic Anemia and Myelodysplastic Syndrome (MDS) International Foundation, and formerly chaired the Oncologic Drugs Advisory Committee of the F.D.A, the MDS Research Fund of the Dresner Foundation, and the Cleveland Clinic Enterprise Pharmacy & Therapeutics Committee, where he was also Vice-chair for Clinical Research of the cancer center. An invited speaker at numerous meetings, grand rounds, and conferences, Dr Sekeres is a member of the American Society of Hematology, where he serves on the Executive Committee and chairs the Committee on Communications, the American Society of Clinical Oncology, and the Southwest Oncology Group—Leukemia Committee. His research focuses on patients with MDS and older adults with acute myeloid leukemia, and he has been the national and international primary study investigator on dozens of phase I/II/III trials. He is the author or co-author of over 400 manuscripts and 650 abstracts published in leading journals such as NEJM, Blood, Journal of Clinical Oncology, Nature Genetics, Cancer Cell, Journal of the National Cancer Institute, Journal of Clinical Investigation, PLoS One, and Leukemia. He was the inaugural editor-in-chief of the ASH Clinical News magazine; he is on the editorial board of several journals; has written 60 essays for The New York Times; and has authored 8 books, including When Blood Breaks Down: Life Lessons from Leukemia (The MIT Press 2020) and Drugs and the FDA: Safety, Efficacy, and the Public’s Trust (The MIT Press 2022).
Read more Read less
Not an Audible member?
From £5.99/month after 30 days. Renews automatically. See here for eligibility.
Start your free 30-day trial

Best Sellers

Product list
  • When Blood Breaks Down cover art

    £13.52 or free with trial. Auto-renews at £5.99/month after trial. See eligibility.

    Try Standard free
  • Drugs and the FDA cover art

    £14.49 or free with trial. Auto-renews at £5.99/month after trial. See eligibility.

    Try Standard free

Are you an author?

Help us improve our Author Pages by updating your bibliography and submitting a new or current image and biography.
Visit Amazon Author Central